ADGM

Adagio Medical Holdings, Inc. (ADGM) SWOT Analysis Analysis (2026)

Invetso Score: 2.4/10 — Weak · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Strengths

Score: 2.1 (Weak)

Liquidity ratios above 1.0 indicate near-term obligations are covered, leaving ADGM less exposed than more levered peers to immediate funding stress.

Negative net debt to EBITDA suggests net cash or minimal net leverage, which structurally compares favorably with indebted peers in capital-intensive financial infrastructure.

The absence of reported operating and gross margins limits evidence of operating strength, but balance-sheet resilience remains the clearest relative advantage versus weaker peers.

Weaknesses

Score:

Return on invested capital is deeply negative, showing capital deployment is destroying value and lagging peers that compound invested capital efficiently.

Cash conversion cycle is extremely elevated, indicating working-capital drag that ties up liquidity far longer than peers and suppresses reinvestment capacity.

Debt-to-equity is highly negative and likely reflects an abnormal capital structure, which weakens comparability and signals fragile equity economics versus peers.

Opportunities

Score:

If working-capital intensity normalizes, cash release could improve liquidity and operating flexibility faster than peers with already efficient cycles.

A cleaner capital structure could improve investor comparability and valuation relative to peers if balance-sheet presentation stabilizes over time.

With leverage currently low, incremental growth could translate into stronger equity returns than highly levered peers if operating efficiency improves.

Threats

Score:

Persistent negative ROIC threatens long-term competitiveness because peers with positive capital returns can reinvest faster and widen structural gaps.

An extreme cash conversion cycle increases execution risk, since peers with shorter cycles can self-fund operations while ADGM remains working-capital constrained.

Limited margin disclosure and weak profitability metrics raise the risk that peers with clearer earnings quality will attract capital and strategic attention.

Overall Score

Score:

ADGM’s structural positioning versus peers is weak overall, as balance-sheet liquidity is offset by deeply negative capital returns and severe working-capital inefficiency.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Adagio Medical Holdings, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →